Bayer AG (BAYRY)
5.41
+0.05
(+0.93%)
USD |
OTCM |
Nov 14, 15:59
Bayer Price to Book Value: 0.5557 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 13, 2024 | 0.5506 |
November 12, 2024 | 0.5732 |
November 11, 2024 | 0.6626 |
November 08, 2024 | 0.6647 |
November 07, 2024 | 0.677 |
November 06, 2024 | 0.6616 |
November 05, 2024 | 0.6945 |
November 04, 2024 | 0.6945 |
November 01, 2024 | 0.6986 |
October 31, 2024 | 0.6955 |
October 30, 2024 | 0.6996 |
October 29, 2024 | 0.714 |
October 28, 2024 | 0.7284 |
October 25, 2024 | 0.7181 |
October 24, 2024 | 0.7171 |
October 23, 2024 | 0.7129 |
October 22, 2024 | 0.7212 |
October 21, 2024 | 0.7263 |
October 18, 2024 | 0.7386 |
October 17, 2024 | 0.7381 |
October 16, 2024 | 0.7412 |
October 15, 2024 | 0.7427 |
October 14, 2024 | 0.7325 |
October 11, 2024 | 0.7448 |
October 10, 2024 | 0.7554 |
Date | Value |
---|---|
October 09, 2024 | 0.77 |
October 08, 2024 | 0.827 |
October 07, 2024 | 0.8403 |
October 04, 2024 | 0.8444 |
October 03, 2024 | 0.8475 |
October 02, 2024 | 0.8619 |
October 01, 2024 | 0.864 |
September 30, 2024 | 0.8701 |
September 27, 2024 | 0.8711 |
September 26, 2024 | 0.8362 |
September 25, 2024 | 0.8249 |
September 24, 2024 | 0.8342 |
September 23, 2024 | 0.8177 |
September 20, 2024 | 0.8208 |
September 19, 2024 | 0.8301 |
September 18, 2024 | 0.8003 |
September 17, 2024 | 0.7828 |
September 16, 2024 | 0.7674 |
September 13, 2024 | 0.7715 |
September 12, 2024 | 0.7664 |
September 11, 2024 | 0.7705 |
September 10, 2024 | 0.7828 |
September 09, 2024 | 0.8164 |
September 06, 2024 | 0.8229 |
September 05, 2024 | 0.827 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5506
Minimum
Nov 13 2024
1.851
Maximum
Jul 06 2020
1.328
Average
1.415
Median
Price to Book Value Benchmarks
CureVac NV | 1.492 |
Affimed NV | 1.860 |
InflaRx NV | 1.361 |
BioNTech SE | 1.161 |
Immatics NV | 2.108 |
Price to Book Value Related Metrics
PS Ratio | 0.4170 |
Price to Free Cash Flow | 3.431 |
Price | 5.41 |
Earnings Yield | -6.54% |
Market Cap | 21.26B |
Operating PE Ratio | 2.051 |